Notably, prognostic implications differ by cancer type: Vimentin predicts poor outcomes in lung cancer (Bronte et al., 2021) but exhibits protective effects in PCa (Choudhry et al., 2023). This evidence concerns the gene VIM and posterior cortical atrophy.